Source: United States & Canada – South China Morning PostPfizer expects a Covid-19 vaccine targeting the Omicron variant to be ready in March, the company’s head said Monday.Pfizer Chief Executive Officer Albert Bourla told CNBC that Pfizer is already manufacturing doses due to keen interest from governments, as authorities contend with huge Covid-19 infection counts, including large numbers of “breakthrough” Omicron cases in vaccinated populations.“This vaccine will be ready in March,” Bourla told the network.“I don’t know if we will need it. I don…Read More